Pacer Advisors Inc. Has $85.48 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Pacer Advisors Inc. increased its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 15,105.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,503,591 shares of the medical instruments supplier’s stock after acquiring an additional 4,473,972 shares during the period. Pacer Advisors Inc. owned about 2.27% of DENTSPLY SIRONA worth $85,478,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. increased its stake in shares of DENTSPLY SIRONA by 430.3% in the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP bought a new position in DENTSPLY SIRONA in the third quarter valued at about $27,000. Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the third quarter worth about $35,000. MassMutual Private Wealth & Trust FSB boosted its stake in shares of DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after purchasing an additional 1,232 shares in the last quarter. Finally, Van ECK Associates Corp bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $42,000. 95.70% of the stock is owned by institutional investors.

DENTSPLY SIRONA Trading Up 0.5 %

Shares of NASDAQ XRAY opened at $19.53 on Monday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA Inc. has a twelve month low of $17.21 and a twelve month high of $35.68. The firm has a fifty day simple moving average of $19.03 and a 200 day simple moving average of $22.66.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.49 earnings per share. On average, equities research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date of this dividend was Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.

Wall Street Analyst Weigh In

Several brokerages recently commented on XRAY. Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Mizuho assumed coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 target price for the company. Needham & Company LLC cut their price target on DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Finally, Jefferies Financial Group downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their price objective for the company from $30.00 to $20.00 in a research note on Thursday. Ten investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $26.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.